PROTECTION FROM ROUTINE VACCINATION AT THE AGE OF 14 MONTHS WITH MENINGOCOCCAL SEROGROUP C CONJUGATE VACCINE IN THE NETHERLANDS
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Routine vaccination with a single dose of conjugated meningococcal C vaccine at 14 months and a catch-up campaign have reduced the incidence of meningococcal C disease in the Netherlands. In contrast to countries where routine vaccination is given in infancy, vaccine failures were not reported. This suggests that one dose of conjugated vaccine in the second year of life might offer longer lasting protection against meningococcal C disease than 3 doses in infancy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Effectiveness of meningococcal serogroup C conjugate vaccine 4 years after introduction
Trotter, C. L., Andrews, N. J., Kaczmarski, E. B., Miller, E., & Ramsay, M. E. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16725-1 · Cited by 571
Ramsay, M. E., McVernon, J., Andrews, N. J., Heath, P. T., & Slack, M. P. (2003) · The Journal of Infectious Diseases · doi:10.1086/376997 · Cited by 172
Cited by
Maintaining protection against invasive bacteria with protein–polysaccharide conjugate vaccines
Pollard, A. J., Perrett, K. P., & Beverley, P. C. (2009) · Nature Reviews Immunology · doi:10.1038/nri2494 · Cited by 485
The changing and dynamic epidemiology of meningococcal disease
Halperin, S. A., Bettinger, J. A., Greenwood, B., Harrison, L. H., Jelfs, J., Ladhani, S. N., McIntyre, P., Ramsay, M. E., & Sáfadi, M. A. P. (2012) · Vaccine · doi:10.1016/j.vaccine.2011.12.032 · Cited by 307
Protein carriers of conjugate vaccines: Characteristics, development and clinical trials
Pichichero, M. E. (2013) · Human vaccines & immunotherapeutics · doi:10.4161/hv.26109 · Cited by 261
Trotter, C. L., & Maiden, M. C. (2009) · Expert Review of Vaccines · doi:10.1586/erv.09.48 · Cited by 203
Meningococcal C conjugate vaccine: the experience in England and Wales
Campbell, H., Borrow, R., Salisbury, D., & Miller, E. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.04.067 · Cited by 168
Metadata
- Authors
- de Greeff, S. C., de Melker, H. E., Spanjaard, L., Schouls, L. M., & van DerEnde, A.
- Venue
- Pediatric Infectious Disease Journal
- Published
- 2006-01
- Volume
- 25
- Issue
- 1
- Pages
- 79-80
- ISSN
- 0891-3668 (ISSN-L)
- OpenAlex
- W2061372708
- Cited by
- 131
- References
- 2
- FWCI
- 11.52
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: PROTECTION FROM ROUTINE VACCINATION AT THE AGE OF 14 MONTHS WITH MENINGOCOCCAL SEROGROUP C CONJUGATE VACCINE IN THE NETHERLANDS. https://app.cochat.ai/papers/10.1097/01.inf.0000195594.41449.c6
- The paper
- de Greeff, S. C., de Melker, H. E., Spanjaard, L., Schouls, L. M., & van DerEnde, A. (2006). PROTECTION FROM ROUTINE VACCINATION AT THE AGE OF 14 MONTHS WITH MENINGOCOCCAL SEROGROUP C CONJUGATE VACCINE IN THE NETHERLANDS. Pediatric Infectious Disease Journal. https://doi.org/10.1097/01.inf.0000195594.41449.c6
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.